Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2
The NM_000368.5(TSC1):c.1136C>T(p.Thr379Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★). Synonymous variant affecting the same amino acid position (i.e. T379T) has been classified as Likely benign.
TSC1 (HGNC:12362): (TSC complex subunit 1) This gene is a tumor suppressor gene that encodes the growth inhibitory protein hamartin. The encoded protein interacts with and stabilizes the GTPase activating protein tuberin. This hamartin-tuberin complex negatively regulates mammalian target of rapamycin complex 1 (mTORC1) signaling which is a major regulator of anabolic cell growth. This protein also functions as a co-chaperone for Hsp90 that inhibits its ATPase activity. This protein functions as a facilitator of Hsp90-mediated folding of kinase and non-kinase clients, including TSC2 and thereby preventing their ubiquitination and proteasomal degradation. Mutations in this gene have been associated with tuberous sclerosis and lymphangioleiomyomatosis. [provided by RefSeq, May 2022]
TSC1 Gene-Disease associations (from GenCC):
tuberous sclerosis
Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
tuberous sclerosis 1
Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, PanelApp Australia, Genomics England PanelApp, G2P, Labcorp Genetics (formerly Invitae)
lung lymphangioleiomyomatosis
Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp
tuberous sclerosis complex
Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
In summary, this variant is a novel missense change with uncertain impact on protein function. It has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; PolyPhen-2: "Probably Damaging"; Align-GVGD: "Class C0"). This variant is not present in population databases (ExAC no frequency) and has not been reported in the literature in individuals with a TSC1-related disease. This sequence change replaces threonine with isoleucine at codon 379 of the TSC1 protein (p.Thr379Ile). The threonine residue is moderately conserved and there is a moderate physicochemical difference between threonine and isoleucine. -
Loss of glycosylation at T379 (P = 0.0281);.;Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);.;Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);Loss of glycosylation at T379 (P = 0.0281);.;